NovoCure Limited Earnings Per Share (Basic)
NovoCure Limited (NVCR) reported Earnings Per Share (Basic) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-23
- NovoCure Limited earnings per share, basic for the quarter ending 2026-06-30 was -$0.13.
- NovoCure Limited earnings per share, basic for the quarter ending 2026-03-31 was -$0.62.
- NovoCure Limited earnings per share, basic for the quarter ending 2025-09-30 was -$0.33.
- NovoCure Limited earnings per share, basic for the quarter ending 2025-06-30 was -$0.36.
- NovoCure Limited earnings per share, basic for fiscal 2024 was -$1.56.
- NovoCure Limited earnings per share, basic for fiscal 2023 was -$1.95.
- NovoCure Limited earnings per share, basic for fiscal 2022 was -$0.88.
- NovoCure Limited earnings per share, basic for fiscal 2021 was -$0.56, a 380.00% decline from fiscal 2020.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-07-23 | -$0.75 10-Q · filed 2026-07-23 | ||
| 2026-03-31 | -$0.62 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$1.22 10-Q · filed 2026-07-23 | |||
| 2025-09-30 | -$0.33 10-Q · filed 2025-10-30 | -$1.00 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | -$0.36 10-Q · filed 2026-07-23 | -$0.67 10-Q · filed 2026-07-23 | ||
| 2025-03-31 | -$0.31 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$1.56 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$0.28 10-Q · filed 2025-10-30 | -$0.95 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | -$0.31 10-Q · filed 2025-07-24 | -$0.67 10-Q · filed 2025-07-24 | ||
| 2024-03-31 | -$0.36 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | -$1.95 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$0.46 10-Q · filed 2024-10-30 | -$1.51 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | -$0.54 10-Q · filed 2024-07-25 | -$1.04 10-Q · filed 2024-07-25 | ||
| 2023-03-31 | -$0.50 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$0.36 10-K · filed 2023-02-23 | -$0.88 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$0.25 10-Q · filed 2023-10-26 | -$0.53 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | -$0.23 10-Q · filed 2023-07-27 | -$0.27 10-Q · filed 2023-07-27 | ||
| 2022-03-31 | -$0.04 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$0.25 10-K · filed 2023-02-23 | -$0.56 10-K · filed 2024-02-22 | ||
| 2021-09-30 | -$0.13 10-K · filed 2023-02-23 | -$0.31 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | -$0.14 10-K · filed 2023-02-23 | -$0.18 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | -$0.04 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $0.05 10-K · filed 2023-02-23 | $0.20 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $0.09 10-K · filed 2023-02-23 | $0.15 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | $0.02 10-K · filed 2023-02-23 | $0.06 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.04 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $0.04 10-K · filed 2022-02-24 | -$0.07 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $0.02 10-K · filed 2022-02-24 | -$0.12 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | -$0.01 10-K · filed 2022-02-24 | -$0.14 10-Q/A · filed 2020-10-02 | ||
| 2019-03-31 | -$0.13 10-K · filed 2022-02-24 | |||
| 2018-12-31 | -$0.69 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$0.13 10-Q · filed 2019-10-31 | -$0.52 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |